The Discounted Cash Flow (DCF) valuation of GlaxoSmithKline PLC (GSK.L) is 1,696.50 GBP. With the latest stock price at 1,383.00 GBP, the upside of GlaxoSmithKline PLC based on DCF is 22.7%.
Based on the latest price of 1,383.00 GBP and our DCF valuation, GlaxoSmithKline PLC (GSK.L) is a buy. buying GSK.L stocks now will result in a potential gain of 22.7%.
| Range | Selected | |
| WACC / Discount Rate | 7.5% - 9.9% | 8.7% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 1,248.38 - 2,573.16 | 1,696.50 |
| Upside | -9.7% - 86.1% | 22.7% |